Hypertension

Also known as: high blood pressure

Definition

Hypertension is persistently elevated pressure in the arteries — diagnosed, under the World Health Organization’s criterion, when blood pressure on two different days is 140/90 mmHg or higher (systolic 140 or above and/or diastolic 90 or above). The 2017 American College of Cardiology/American Heart Association guideline lowered the United States threshold to 130/80 mmHg (“stage 1 hypertension”), while European and WHO guidance retain 140/90, so the same patient can be classified hypertensive in one system and not in another. The condition is called the “silent killer” because it usually causes no symptoms while it damages the heart, brain, kidneys, and eyes; about 90–95 percent of cases are essential (primary) hypertension with no single identifiable cause, and 5–10 percent are secondary to conditions such as kidney disease. (WHO — Hypertension Fact Sheet, Wikipedia — Hypertension)

The burden falls heavily on the Philippines: the World Health Organization estimates that hypertension affects one in three Filipino adults — about 16.8 million people — and that before recent programmatic efforts only 19 percent of them had their condition under control. Raised blood pressure is the single largest driver of the cardiovascular disease — the heart attacks and strokes — that top Philippine mortality tables, a framing documented in this wiki’s Cardiovascular Disease entry. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)

Identities

Source	Identifier	URL
Wikipedia	Hypertension	https://en.wikipedia.org/wiki/Hypertension
Wikidata	Hypertension (Q41861)	https://www.wikidata.org/wiki/Q41861
DBpedia	Hypertension	https://dbpedia.org/page/Hypertension
ProductOntology	N/A	N/A
Wiktionary	hypertension	https://en.wiktionary.org/wiki/hypertension
Library of Congress Subject Headings (LCSH)	N/A	N/A
MeSH	Hypertension (D006973)	https://meshb.nlm.nih.gov/record/ui?ui=D006973
NCBI Taxonomy	N/A	N/A
AGROVOC	N/A	N/A
Google Scholar	hypertension Philippines prevalence 140/90 ACC AHA 130/80 treatment control DOH	N/A
ConceptNet	N/A	N/A
OpenCyc	N/A	N/A

Also Known As

high blood pressure

Examples and Analogies

Plumbing run past its rating: hypertension is a building’s water system run at pressures the pipes were never rated for — nothing bursts for years, but the constant overload stiffens vessels, strains the pump, and eventually bursts a pipe in the brain (haemorrhagic stroke) or helps clot off a narrowed one (ischaemic stroke). (Wikipedia — Hypertension)
The threshold families: a reading of 135/85 is “normal” under WHO’s 140/90 rule but already “stage 1 hypertension” under the 2017 ACC/AHA definition — the two thresholds are not a dispute about biology but about where the treatment benefits outweigh the costs of labeling and medicating. (WHO — Hypertension Fact Sheet, Wikipedia — Hypertension)
The silent queue at the barangay hall: a market vendor measured at 150/95 at a community screening feels entirely well — she is one of the estimated 44 percent of people with hypertension worldwide who do not know they have it, and one of the 16.8 million Filipinos the health system must find, treat, and keep in care. (WHO — Hypertension Fact Sheet, WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)
Verified epidemiological data:
Global scale: an estimated 1.4 billion adults aged 30–79 had hypertension in 2024 — 33 percent of that age group, up from 650 million in 1990; about two-thirds of cases are in low- and middle-income countries
Care cascade: about 600 million (44 percent) are unaware; about 630 million (44 percent) are diagnosed and treated; only about 320 million (23 percent) have it controlled
Philippines: one in three adults affected, about 16.8 million people; 19 percent controlled before the recent program scale-up
Diagnosis: 140/90 mmHg or higher on two days (WHO/Philippine practice); 130/80 mmHg threshold in the US since 2017
Subtypes: essential hypertension 90–95 percent of cases; secondary 5–10 percent, most often from kidney disease (WHO — Hypertension Fact Sheet, WHO Western Pacific — Stronger systems for healthy hearts in the Philippines, Wikipedia — Hypertension)

Usage Scenarios

1. Community Screening and Case Finding

Because the condition is silent, finding it is an active operation: Philippine primary care under the Department of Health measures blood pressure at every contact, from barangay health stations to Konsulta check-ups, following the WHO-DOH model in which community teams — over 1,400 doctors, nurses, and midwives trained to date — screen adults and enroll the hypertensive into registries rather than waiting for symptoms. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)

2. Diagnosis and Staging in the Clinic

A suspected case is confirmed with readings on two separate days at 140/90 or higher; severe elevations — typically 180/120 or above — present with headaches, chest pain, dizziness, blurred vision, or nosebleeds and need urgent care, while the ordinary confirmed case is staged, examined for organ damage, and assessed for secondary causes before long-term treatment begins. (WHO — Hypertension Fact Sheet, Wikipedia — Hypertension)

3. Pharmacotherapy for Life

Confirmed patients are managed, usually for life, with the standard drug classes named in WHO guidance — ACE inhibitors (enalapril, lisinopril), angiotensin receptor blockers (losartan, telmisartan), calcium channel blockers (amlodipine, felodipine), and diuretics (hydrochlorothiazide, chlorthalidone) — in affordable generic form, which is why losartan and amlodipine top Philippine household medicine purchases under the generics regime this wiki documents. (WHO — Hypertension Fact Sheet, PMC — Household Out-of-Pocket Expenditures for NCDs in the Philippines)

4. Household Budget Management of a Chronic Disease

For a Filipino family, hypertension is a monthly bill: in a 2025 Cavite study of households with noncommunicable disease members, hypertensive disease was the most prevalent condition, medicines — led by losartan and amlodipine — drove spending, and the median monthly cost of NCD medicines ran to ₱1,140 against total health spending with a median NCD-medicine share of 59.41 percent. (PMC — Household Out-of-Pocket Expenditures for NCDs in the Philippines)

Strategies

Protocolize primary care rather than depend on specialists: the Healthy Hearts Philippines approach — standard treatment protocols, validated blood-pressure devices, and a digital patient registry embedded in ordinary primary care — brought 80 percent of enrolled patients under control in its Iloilo pilot against a 19-percent national baseline, and nearly two-thirds across more than 139,000 enrollees. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)
Attack the modifiable drivers: WHO’s prevention package — salt under 2 grams of sodium daily, at least 150 minutes of moderate or 75 minutes of vigorous activity weekly plus strength training twice weekly, weight control, no tobacco, and limited alcohol — targets the inputs that raise pressure in the first place. (WHO — Hypertension Fact Sheet)
Finance the medicines, not just the consult: with NCD medicines consuming the majority of affected households’ health spending and driving catastrophic expenditure, PhilHealth’s Konsulta package financing drugs and diagnostics is the documented Philippine answer to keeping treatment affordable. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines, PMC — Household Out-of-Pocket Expenditures for NCDs in the Philippines)
Treat to the national threshold consistently: the WHO/Philippine goal for most patients is below 140/90 — tighter, under 130/80, only for those with existing cardiovascular disease, diabetes, kidney disease, or high cardiovascular risk — a target hierarchy that keeps treatment intensity proportionate. (WHO — Hypertension Fact Sheet)
Close the awareness gap first: with 44 percent of the world’s hypertensives unaware, and detection in the Philippines historically late, the highest-yield intervention remains the cheapest — measuring blood pressure everywhere the public already is. (WHO — Hypertension Fact Sheet)

Security and Safety Measures

Never start, stop, or adjust medication without a clinician: antihypertensives are a lifelong regimen in most patients, and self-titrated or interrupted treatment is the documented route to uncontrolled pressure and crisis. (WHO — Hypertension Fact Sheet)
Know the crisis signs: severe hypertension — usually 180/120 and above — is the point where the “silent” disease stops being silent: severe headache, chest pain, dizziness, breathing difficulty, nausea, vomiting, blurred vision, confusion, and nosebleeds warrant urgent care. (WHO — Hypertension Fact Sheet)
Confirm before labeling: diagnosis requires high readings on two different days, protecting patients from a single stressful measurement — white-coat or otherwise — becoming a permanent diagnosis and prescription. (WHO — Hypertension Fact Sheet)
Check blood-pressure devices and technique: the Philippine program’s use of validated devices and standard protocols is not bureaucratic detail — inaccurate cuffs and casual measurement are how both false reassurance and false diagnosis happen. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)
Beware salt-reduction shortcuts and cure claims: the prevention evidence sits with sodium reduction, diet, and activity as WHO defines them, not with unverified supplements marketed to “clean” the blood vessels. (WHO — Hypertension Fact Sheet)

Historical Context

Hypertension’s modern history is a widening epidemic measured by an improving apparatus. In 1990 an estimated 650 million adults aged 30–79 had the condition; by 2024 the number had reached 1.4 billion — 33 percent of that age group — with the growth concentrated in low- and middle-income countries that now hold two-thirds of cases. The definitional history runs the other way, toward caution: the 2017 ACC/AHA guideline’s drop of the US threshold to 130/80 remains an outlier against the 140/90 criterion maintained by WHO and European guidance, a divergence that reclassifies millions at a stroke without changing anyone’s blood pressure. (WHO — Hypertension Fact Sheet, Wikipedia — Hypertension)

The Philippine response is a documented program arc. Healthy Hearts Philippines — launched in 2018 by the Department of Health with WHO and Resolve to Save Lives — embedded hypertension care in primary health services, trained over 1,400 clinicians, and leaned on barangay health workers to deliver monitoring and medicines; the 2021 Iloilo pilot brought 80 percent of 25,000 enrolled adults under control, and the program has since enrolled over 139,000 patients across Western Visayas and the Cagayan Valley, reaching 194 local governments and a targeted 5.3 million adults. The remaining history is being written against the household economics: hypertension dominates out-of-pocket NCD spending in measured communities, and catastrophic-expenditure studies now define the frontier. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines, PMC — Household Out-of-Pocket Expenditures for NCDs in the Philippines)

Challenges and Controversies

The Awareness and Control Gap

The central failure is upstream of any hospital: 44 percent of the world’s hypertensives do not know they have it, only 23 percent are controlled, and the Philippine baseline was 19 percent control — a gap produced by the disease’s silence, late screening, and follow-up systems that lose patients between visits. (WHO — Hypertension Fact Sheet, WHO Western Pacific — Stronger systems for healthy hearts in the Philippines)

Two Thresholds, One Patient

The 2017 US redefinition to 130/80 created a lasting controversy: its proponents argue earlier treatment prevents events, its critics that it medicalizes millions overnight and strains low-resource systems — a debate with direct Philippine resonance, since national practice retains 140/90 even as Filipino clinicians read the American literature. (Wikipedia — Hypertension, WHO — Hypertension Fact Sheet)

The Price of Lifelong Pills

Treatment is cheap per tablet and expensive per lifetime: in the measured Cavite households, NCD medicines took a median 59.41 percent of health spending at ₱1,140 monthly median cost, 74 percent of households crossed the 10-percent catastrophic-expenditure threshold, and families coped by borrowing money, using savings, and seeking cheaper alternatives — the documented cost side of “cheap” generic therapy. (PMC — Household Out-of-Pocket Expenditures for NCDs in the Philippines)

Keeping Millions in Care

Even enrolled patients drift: the Philippine program’s nearly two-thirds control rate among enrollees is triple the national baseline but still leaves a third uncontrolled, and WHO’s global target — a 25-percent reduction in uncontrolled hypertension prevalence between 2010 and 2025 — quantifies how far the care cascade leaks between diagnosis, prescription, and sustained adherence. (WHO Western Pacific — Stronger systems for healthy hearts in the Philippines, WHO — Hypertension Fact Sheet)